(Q37121048)

18 August 2017

A simulation study to evaluate the impact of the number of lesions measured on response assessment (English)

1 reference

18 August 2017

4

Mithat Gönen

0 references

Chaya S Moskowitz

series ordinal

1

object named as

Chaya S Moskowitz

1 reference

18 August 2017

Xiaoyu Jia

2

1 reference

18 August 2017

Lawrence H Schwartz

series ordinal

3

1 reference

18 August 2017

Mithat Gönen

series ordinal

4

1 reference

18 August 2017

16 December 2008

1 reference

European Journal of Cancer

18 August 2017

1 reference

18 August 2017

45

1 reference

18 August 2017

2

1 reference

18 August 2017

300-310

1 reference

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652848

Individual patient data analysis to assess modifications to the RECIST criteria.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652848

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652848

Reporting results of cancer treatment

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652848

Analysis of interobserver and intraobserver variability in CT tumor measurements

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652848

Optimal two-stage designs for phase II clinical trials

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652848

Design of phase II cancer trials using a continuous endpoint of change in tumor size: application to a study of sorafenib and erlotinib in non small-cell lung cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652848

Variability in response assessment in solid tumors: effect of number of lesions chosen for measurement.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652848

Evaluation of tumor measurements in oncology: use of film-based and electronic techniques.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2652848

10.1016/J.EJCA.2008.11.010

3 September 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19095439

1 reference